Immunic Stock Buy Hold or Sell Recommendation

IMUX -  USA Stock  

USD 8.43  0.06  0.71%

Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Immunic is 'Buy'. Macroaxis provides Immunic buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Immunic positions. The advice algorithm takes into account all of Immunic's available fundamental, technical, and predictive indicators you will find on this site.

Immunic Advice 

 
Refresh
The advice is provided from Immunic's buy-and-hold perspective. Please see Immunic Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Immunic and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Immunic.

Execute Immunic Buy or Sell Advice

The Immunic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Immunic. Macroaxis does not own or have any residual interests in Immunic or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Immunic's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell ImmunicBuy Immunic
Buy

Volatility

Not too volatileDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Close to AverageDetails

Economic Sensitivity

Almost mirrors the marketDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

Very WeakDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Immunic has a Risk Adjusted Performance of (0.005859), Jensen Alpha of (0.15), Total Risk Alpha of (0.40) and Treynor Ratio of (0.08)
We provide advice to complement the regular expert consensus on Immunic. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Immunic is not overpriced, please check out all Immunic fundamentals, including its book value per share, and the relationship between the net income and beta . Given that Immunic has a price to earning of (6.65) X, we strongly advise you to confirm Immunic market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Immunic Trading Alerts and Improvement Suggestions

Immunic generated a negative expected return over the last 90 days
Immunic has high historical volatility and very poor performance
Immunic has high likelihood to experience some financial distress in the next 2 years
Immunic was previously known as Vital Therapies and was traded on NMS Exchange under the symbol VTL.
Net Loss for the year was (76.54 M) with loss before overhead, payroll, taxes, and interest of (4.91 K).
Immunic currently holds about 87.17 M in cash with (67.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.32.
Immunic has a very weak financial position based on the latest SEC disclosures
Roughly 25.0% of the company shares are held by company insiders
Latest headline from www.equities.com: Immunic gains 3.34 percent on Moderate Volume October 15 - Equities.com

Immunic current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immunic analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immunic analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price54.50
Target Median Price57.50
Target High Price71.00
Recommendation Mean1.60
Number Of Analyst Opinions8
Target Low Price25.00
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Immunic Returns Distribution Density

The distribution of Immunic's historical returns is an attempt to chart the future uncertainty of Immunic's future price movements. The chart of the probability distribution of Immunic stock daily returns describes the distribution of returns around its average expected value. We use Immunic price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Immunic returns is essential to provide solid investment advice for Immunic stock.
Mean Return-0.08Value At Risk-4.97
Potential Upside6.18Standard Deviation4.03
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Immunic historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Immunic Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Immunic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immunic backward and forwards among themselves. Immunic's institutional investor refers to the entity that pools money to purchase Immunic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Golden Green IncCommon Shares87.1 K771 K
Omega Fund Management LlcCommon Shares1.8 M21.9 M
Fmr LlcCommon Shares1.2 M14.6 M
Blackrock IncCommon Shares1.1 M13.8 M
Rtw Investments LpCommon Shares920.8 K11.3 M
Vanguard Group IncCommon Shares711.8 K8.7 M
Artal Group SaCommon Shares700 K8.6 M
Note, although Immunic's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immunic Cash Flow Accounts

201620172018201920202021 (projected)
Capital Expenditure(554 K)(678 K)(32 K)(15 K)(146 K)(157.53 K)
Depreciation Amortization and Accretion1.81 M998 K15 K50 K39 K40.03 K
Net Cash Flow or Change in Cash and Cash Equivalents(23.43 M)(3.09 M)8.57 M16.3 M98.08 M105.83 M
Issuance Purchase of Equity Shares32.7 M12.39 M38 M35.16 M144.43 M155.83 M
Net Cash Flow from Financing12.37 M37.98 M19.26 M34.9 M144.43 M155.83 M
Net Cash Flow from Investing(21 K)(678 K)(32 K)10.54 M(146 K)(149.84 K)
Net Cash Flow from Operations(35.77 M)(40.4 M)(9.74 M)(28.55 M)(46.12 M)(49.77 M)
Effect of Exchange Rate Changes on Cash(4 K)1,000(918 K)(589 K)(78 K)(84.16 K)
Share Based Compensation4.03 M4.68 M5.74 M6.51 M2.75 M3.42 M

Immunic Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immunic or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immunic stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immunic stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.15
β
Beta against DOW1.10
σ
Overall volatility
4.11
Ir
Information ratio -0.04

Immunic Volatility Alert

Immunic exhibits very low volatility with skewness of 0.52 and kurtosis of 2.19. However, we advise investors to further study Immunic technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immunic's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immunic's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Immunic Fundamentals Vs Peers

Comparing Immunic's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Immunic's direct or indirect competition across all of the common fundamentals between Immunic and the related equities. This way, we can detect undervalued stocks with similar characteristics as Immunic or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Immunic's fundamental indicators could also be used in its relative valuation, which is a method of valuing Immunic by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Immunic to competition
FundamentalsImmunicPeer Average
Return On Equity(76.76) %(0.31) %
Return On Asset(34.74) %(0.14) %
Current Valuation161.11 M16.62 B
Shares Outstanding21.75 M571.82 M
Shares Owned by Insiders24.60 %10.09 %
Shares Owned by Institutions37.51 %39.21 %
Number of Shares Shorted962.43 K4.71 M
Price to Earning(6.65) X28.72 X
Price to Book1.13 X9.51 X
Gross Profit(4.91 K)27.38 B
EBITDA(61.99 M)3.9 B
Net Income(76.54 M)570.98 M
Cash and Equivalents87.17 M2.7 B
Cash per Share3.32 X5.01 X
Total Debt1.02 M5.32 B
Debt to Equity0.008 %48.70 %
Current Ratio7.02 X2.16 X
Book Value Per Share7.50 X1.93 K
Cash Flow from Operations(67.82 M)971.22 M
Short Ratio5.04 X4.00 X
Earnings Per Share(2.81) X3.12 X
Price to Earnings To Growth(0.17) X4.89 X
Number of Employees4518.84 K
Beta1.95-0.15
Market Capitalization184.65 M19.03 B
Total Asset33.9 M29.47 B
Retained Earnings(64.64 M)9.33 B
Working Capital27.6 M1.48 B
Current Asset32.33 M9.34 B
Current Liabilities4.73 M7.9 B
   Purchase by Daniel Vitt of 1000 shares of Immunic [view details]

Immunic Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Immunic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution6592.04
Daily Balance Of Power(0.16)
Rate Of Daily Change0.99
Day Median Price8.34
Day Typical Price8.37
Market Facilitation Index0.0
Price Action Indicator0.06

About Immunic Buy or Sell Advice

When is the right time to buy or sell Immunic? Buying financial instruments such as Immunic Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Immunic investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2018 2019 2020 2021 (projected)
Current Assets13.33 M32.23 M133.75 M105.89 M
Total Assets13.37 M65.95 M167.86 M181.11 M

Use Investing Ideas to Build Portfolios

In addition to having Immunic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recreation Thematic Idea Now

Recreation
Recreation Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Recreation theme has 18 constituents.
View All  Next Launch Recreation
Please see Immunic Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Immunic information on this page should be used as a complementary analysis to other Immunic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Immunic Stock analysis

When running Immunic price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.